Records 1-10 (of 10 Records) |
Query Trace: PTX3[original query] |
---|
Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity. Feitosa Thiala Alves, et al. Clinical and experimental medicine 2022 0 0. |
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Stravalaci Matteo, et al. Nature immunology 2022 0 0. |
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Phetsouphanh Chansavath, et al. Nature immunology 2022 0 0. |
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19. Kerget Ferhan, et al. Journal of medical virology 2021 0 0. |
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules Stravalaci, Matteo et al. medRxiv June 08 2021 |
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Gutmann Clemens et al. Nature communications 2021 6 (1) 3406
We obtained blood samples (n?=?474) from hospitalized COVID-19 patients (n?=?123), non-COVID-19 ICU sepsis patients (n?=?25) and healthy controls (n?=?30). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA was detected in plasma or serum (RNAemia) of COVID-19 ICU patients when neutralizing antibody response was low. RNAemia is associated with higher 28-day ICU mortality (hazard ratio [HR], 1.84 RNAemia is comparable in performance to the best protein predictors.
|
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Quéromès Grégory et al. Emerging microbes & infections 2021 Jan 1-56 |
SARS-CoV-2 RNAemia and proteomic biomarker trajectory inform prognostication in COVID-19 patients admitted to intensive care Mayr, Manuel et al. Research Square November 18 2020 |
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Brunetta Enrico, et al. Nature immunology 2020 0 0. (1) 19-24 |
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 Brunetta, Enrico et al. medRxiv June 29 2020 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 19, 2024
- Content source: